Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2019.11.296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pharmacology of Propranolol in Patients With Cirrhosis and Portal Hypertension.

Gut
Gastroenterology
1985English

Сompetitive Prospects of Portosystemic Shunting in Patients With Liver Cirrhosis and Portal Hypertension

The Bulletin of Contemporary Clinical Medicine
2016English

Colonic Mucosal Changes in Egyptian Patients With Liver Cirrhosis and Portal Hypertension

The Egyptian Journal of Internal Medicine
2013English

Increased Expression of Urotensin II and GPR14 in Patients With Cirrhosis and Portal Hypertension

International Journal of Molecular Medicine
MedicineGenetics
2010English

Impact of Non-Malignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

Liver Transplantation
HepatologyTransplantationSurgery
2019English

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients With Alcoholic Cirrhosis

PLoS ONE
Multidisciplinary
2015English

Presence of Sarcopenia (Muscle Wasting) in Patients With Nonalcoholic Steatohepatitis

Hepatology
MedicineHepatology
2014English

Altered Bile Acid Metabolome in Patients With Nonalcoholic Steatohepatitis

Digestive Diseases and Sciences
PhysiologyGastroenterology
2015English

To Find Relationship Between Colonic Mucosal Changes in Patients of Liver Cirrhosis With Portal Hypertension.

International Journal of Medical and Biomedical Studies
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy